Načítá se...

Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN(®)) in Patients with Diabetic Macular Edema

INTRODUCTION: Patients with diabetic macular edema (DME), a chronic, vision-limiting condition, may be insufficiently responsive to standard-of-care anti-vascular endothelial growth factor (VEGF) and/or laser therapies. One approved treatment for such patients is 0.2 μg/day fluocinolone acetonide (F...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ophthalmol Ther
Hlavní autoři: Elaraoud, Ibrahim, Attawan, Alaa, Quhill, Fahd
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4909672/
https://ncbi.nlm.nih.gov/pubmed/26885863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-016-0045-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!